The YGC's Hiring Brief – Your Gateway to Biotech's Newest Opportunities | September 26, 2025
This isn’t scraped content. Every role here is vetted through YGC’s insider network — these are the opportunities that actually move careers forward.
The job market moves fast. Your career should move faster.
Each week, we curate the hottest roles in rare disease, gene therapy, oncology, and specialty biopharma — not scraped lists, but insider intel vetted through our network. These are the opportunities that matter: high-impact roles at lean, growing companies where disruption creates opportunity.
While others are slowing down, the real moves are happening now — here are the roles worth your attention.
This Week’s Featured Roles
High-Impact Commercial Roles Hiring Right Now in Rare Disease, Gene Therapy, Oncology & Specialty Biopharma
All jobs are active listings at powerful mission-driven teams. Check them out!
Your Competitive Edge, Delivered Weekly
This round-up extends our newsletter's proven approach: quality over quantity, insight over information. While job aggregators throw hundreds of listings at you, we deliver the 10-15 opportunities each week that actually matter for your career trajectory.
Because in biotech, it's not about finding a job – it's about finding the right opportunity at the right time with the right company that positions you for the next decade of your career.
Ready to get ahead while others are standing still?
Don't miss a single opportunity. Subscribe to our newsletter delivered directly to your inbox every Friday, now improved with this special list of handpicked roles you don’t want to miss.
Disc Medicines
We love Disc for its laser focus on hematology and rare blood disorders, where every advancement transforms patient lives. These leadership roles directly shape how innovation reaches the people who need it.
argenx
argenx is leading in antibody innovation with a clear commitment to rare autoimmune diseases. Whether in commercial strategy or medical leadership, these roles influence how breakthroughs become real options for patients.
Insmed
Insmed is relentless in addressing serious and rare diseases, from lung conditions to gene therapy. These commercial and medical affairs roles expand the reach of science to patients worldwide.
VERO Biotech
VERO stands out with its dedication to pulmonary care and patient-friendly nitric oxide delivery. A compliance leader here safeguards both quality and trust.
ANI Pharmaceuticals
ANI has built a reputation for bringing hard-to-make therapies to market fast. The sales team drives access in critical areas like pulmonology where time matters.
Corcept Therapeutics
Corcept focuses on cortisol modulation, an area with huge potential for patients living with cancer and metabolic disease. We love their clear commitment to advancing science into therapies that change outcomes.
Apellis Pharmaceuticals
Apellis is pioneering complement biology to treat rare and common diseases. We love their bold science paired with a patient-first approach that has already reshaped standards of care.
Rezolute
Rezolute is advancing therapies for rare metabolic and endocrine disorders. Their focus on precision and patient need makes every role there directly tied to meaningful impact.
Stay Visible,
The YGC Team